Literature DB >> 30111972

Complementary and alternative medicine use in patients before and after a cancer diagnosis.

C A Buckner1,2, R M Lafrenie1,2, J A Dénommée2, J M Caswell1, D A Want3.   

Abstract

Background: Cancer patients are increasingly seeking out complementary and alternative medicine (cam) and might be reluctant to disclose its use to their oncology treatment team. Often, cam agents are not well studied, and little is known about their potential interactions with chemotherapy, radiation therapy, or biologic therapies, and their correlations with outcomes. In the present study, we set out to determine the rate of cam use in patients receiving treatment at a Northern Ontario cancer centre.
Methods: Patients reporting for treatment at the Northeast Cancer Centre (necc) in Sudbury, Ontario, were asked to complete an anonymous questionnaire to assess cam use. Changes in cam use before, compared with after, diagnosis were also assessed.
Results: Patients in Northern Ontario reported significant cam use both before and after diagnosis. However, as a function of the cam type, cam use was greatly enhanced after cancer diagnosis. For example, the number of patients who reported use of biologic products increased to 51.8% after a cancer diagnosis from 15.6% before a cancer diagnosis. Patients reported much smaller changes in the use of alternative medical systems or spiritual therapy after diagnosis. Vitamin use was reported by 66% of respondents, and the number of different cams used correlated significantly with the reported number of vitamins used. Conclusions: Use of cam, particularly biologic products, increased significantly after a cancer diagnosis. Further studies are required to examine the effect of cam use on the efficacy and safety of cancer therapies.

Entities:  

Keywords:  Complementary and alternative medicine; natural products; questionnaires

Mesh:

Substances:

Year:  2018        PMID: 30111972      PMCID: PMC6092049          DOI: 10.3747/co.25.3884

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  39 in total

1.  Anti-Inflammatory Agents for Cancer Therapy.

Authors:  Elizabeth R Rayburn; Scharri J Ezell; Ruiwen Zhang
Journal:  Mol Cell Pharmacol       Date:  2009

2.  Why patients use alternative medicine: results of a national study.

Authors:  J A Astin
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

3.  Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patients.

Authors:  Carmen Loquai; Dagmar Dechent; Marlene Garzarolli; Martin Kaatz; Katharina C Kaehler; Peter Kurschat; Frank Meiss; Oliver Micke; Ralph Muecke; Karsten Muenstedt; Annette Stein; Dorothée Nashan; Christoph Stoll; Irene Schmidtmann; Jutta Huebner
Journal:  Eur J Cancer       Date:  2016-12-14       Impact factor: 9.162

4.  Anti-inflammatory and antioxidant effect of ginger in tuberculosis.

Authors:  Rashmi Anant Kulkarni; Ajit Ramesh Deshpande
Journal:  J Complement Integr Med       Date:  2016-06-01

5.  [Effectiveness of prayer in reducing anxiety in cancer patients].

Authors:  Camila Csizmar Carvalho; Erika de Cássia Lopes Chaves; Denise Hollanda Iunes; Talita Prado Simão; Cristiane da Silva Marciano Grasselli; Cristiane Giffoni Braga
Journal:  Rev Esc Enferm USP       Date:  2014-08       Impact factor: 1.086

6.  Complementary and alternative medicine use among colorectal cancer patients in Alberta, Canada.

Authors:  Suzanne C Tough; David W Johnston; Marja J Verhoef; Keith Arthur; Heather Bryant
Journal:  Altern Ther Health Med       Date:  2002 Mar-Apr       Impact factor: 1.305

Review 7.  Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials.

Authors:  Lawrence Chen; Chao-Chun Lin; Tsai-Wei Huang; Yi-Chun Kuan; Yao-Hsien Huang; Hung-Chou Chen; Chun-Yu Kao; Chih-Ming Su; Ka-Wai Tam
Journal:  Breast       Date:  2017-04-04       Impact factor: 4.380

8.  Complementary therapy use in metropolitan and regional Australian radiotherapy centres; do patients report effective outcomes?

Authors:  Darren Hunter; Christopher Marinakis; Ruth Salisbury; Alison Cray; Richard Oates
Journal:  Support Care Cancer       Date:  2015-10-08       Impact factor: 3.603

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany.

Authors:  Kerstin A Kessel; Sabrina Lettner; Carmen Kessel; Henning Bier; Tilo Biedermann; Helmut Friess; Peter Herrschbach; Jürgen E Gschwend; Bernhard Meyer; Christian Peschel; Roland Schmid; Markus Schwaiger; Klaus-Dietrich Wolff; Stephanie E Combs
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

View more
  29 in total

1.  Managing Patient Expectations: Integrative, Not Alternative.

Authors:  Shelly Latte-Naor
Journal:  Cancer J       Date:  2019 Sep/Oct       Impact factor: 3.360

2.  The use of complementary and integrative therapies as adjunct interventions during radiotherapy: a systematic review.

Authors:  Kaitlyn Lapen; Elaine Cha; Christina C Huang; David M Rosenberg; Michael K Rooney; Mark McArthur; Ritu Arya; Christina H Son; Anne R McCall; Daniel W Golden
Journal:  Support Care Cancer       Date:  2021-04-06       Impact factor: 3.603

3.  Falcarindiol and dichloromethane fraction are bioactive components in Oplopanax elatus: Colorectal cancer chemoprevention via induction of apoptosis and G2/M cell cycle arrest mediated by cyclin A upregulation.

Authors:  Chong-Zhi Wang; Yun Luo; Wei-Hua Huang; Jinxiang Zeng; Chun-Feng Zhang; Mallory Lager; Wei Du; Ming Xu; Chun-Su Yuan
Journal:  J Appl Biomed       Date:  2021       Impact factor: 1.797

4.  New Approaches in Breast Cancer Therapy Through Green Nanotechnology and Nano-Ayurvedic Medicine - Pre-Clinical and Pilot Human Clinical Investigations.

Authors:  Menka Khoobchandani; Kavita K Katti; Alice Raphael Karikachery; Velaphi C Thipe; Deepak Srisrimal; Darsha Kumar Dhurvas Mohandoss; Rashmi Dhurvas Darshakumar; Chintamani M Joshi; Kattesh V Katti
Journal:  Int J Nanomedicine       Date:  2020-01-13

Review 5.  Pancreas Cancer-Associated Pain Management.

Authors:  Andrew L Coveler; Jonathan Mizrahi; Bory Eastman; Smith Jim Apisarnthanarax; Shalini Dalal; Terry McNearney; Shubham Pant
Journal:  Oncologist       Date:  2021-05-12

6.  Prolonged Neutropenia and Yellowish Discoloration of the Skin, But Not the Sclera, Following Excessive Turmeric Raw Root Ingestion.

Authors:  Rashid Abdel-Razeq; Sereen Iweir; Tala Awabdeh; Fareed Barakat; Hikmat Abdel-Razeq
Journal:  Cureus       Date:  2021-04-29

7.  Enhanced cytotoxic effects of Clinacanthus nutans and doxorubicin in combination toward breast cancer cell lines.

Authors:  Sry Suryani Widjaja; M Ichwan
Journal:  J Adv Pharm Technol Res       Date:  2021-04-27

Review 8.  Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma.

Authors:  Hui Xie; Felix K-H Chun; Jochen Rutz; Roman A Blaheta
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

9.  From their own perspectives: a qualitative study exploring the perceptions of traditional health practitioners in northern Uganda regarding cancers, their causes and treatments.

Authors:  Amos Deogratius Mwaka; Jennifer Achan; Winnie Adoch; Henry Wabinga
Journal:  BMC Fam Pract       Date:  2021-07-19       Impact factor: 2.497

Review 10.  Curcumin-A Viable Agent for Better Bladder Cancer Treatment.

Authors:  Jochen Rutz; Andrea Janicova; Katja Woidacki; Felix K-H Chun; Roman A Blaheta; Borna Relja
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.